Kennedy Lorna J, Lunt Mark, Barnes Annette, McElhinney Lorraine, Fooks Anthony R, Baxter David N, Ollier William E R
Centre for Integrated Genomic Medical Research, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK.
Vaccine. 2007 Dec 12;25(51):8500-7. doi: 10.1016/j.vaccine.2007.10.015. Epub 2007 Oct 26.
Since 2000, there has been a legal requirement in the UK that dogs and cats should have an effective rabies vaccination with demonstrable sero-conversion if their owners wish to avoid quarantine on re-entry to the UK. In 2002, 10,483 rabies titres were determined on dogs at the VLA. Statistical analyses assessed the efficacy of each vaccine within different dog breeds. Animal size, age, breed, sampling time and vaccine had significant effects on pass rates and median titres. Our data suggests that a general relationship between animal size and level of antibody response exists and smaller sized dogs elicited higher antibody levels than larger breeds of dog. It was not however, only the magnitude of response immediately following vaccination but also the duration of immunity that varied between breeds of dog. Another observation was that young animals, less than 1-year of age, generated a lower antibody response to rabies vaccination than adults. Considerably higher failure rates were also observed for different vaccines tested. Regression analysis revealed that two vaccines performed equally well, and significantly better than the others tested. The variation in antibody response relating to length of interval of sampling following vaccination is not unexpected and presumably relates to the response kinetics for primary vaccination. These data need to be placed in perspective in order to minimise the risk of rabies being re-introduced into a rabies-free country, especially in the consideration of removing the requirement for serological testing for rabies vaccinated dogs that participate in pet travel schemes.
自2000年以来,英国有一项法律规定,如果狗和猫的主人希望在重新进入英国时避免检疫,那么这些猫狗必须接种有效的狂犬病疫苗,并要有可证明的血清转化。2002年,英国兽医实验室局(VLA)对10483只狗进行了狂犬病抗体效价测定。统计分析评估了每种疫苗在不同犬种中的效力。动物的体型、年龄、品种、采样时间和疫苗对通过率和抗体效价中位数都有显著影响。我们的数据表明,动物体型与抗体反应水平之间存在一般关系,体型较小的狗比大型犬种产生更高的抗体水平。然而,不同犬种之间不仅在接种疫苗后立即产生的反应强度不同,而且免疫持续时间也有所差异。另一个观察结果是,1岁以下的幼龄动物对狂犬病疫苗产生的抗体反应比成年动物低。对不同测试疫苗也观察到相当高的失败率。回归分析显示,有两种疫苗表现同样良好,且明显优于其他测试疫苗。接种疫苗后采样间隔时间长短与抗体反应的差异并不意外,可能与初次接种的反应动力学有关。为了将狂犬病重新传入无狂犬病国家的风险降至最低,特别是在考虑取消参与宠物旅行计划的接种狂犬病疫苗犬只的血清学检测要求时,需要正确看待这些数据。